Freitag, 26. Februar 2016

Acute Toxicity: inhalation.001 to 002

Acute Toxicity: inhalation.001

Administrative data

Purpose flag:
key study
Study result type:
experimental result
Study period:
From 1995-09-25 to 1995-12-01
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1996
Report Date:
1996

Materials and methods

Test guideline
Qualifier:
according to
Guideline:
EU Method B.2 (Acute Toxicity (Inhalation))
Deviations:
no
Principles of method if other than guideline:
Not applicable
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no

Test materials

Identity of test material same as for substance defined in section 1 (if not read-across):
yes
Test material identityopen allclose all
Identifier:
CAS number
Identity:
10049-04-4
Identifier:
EC number
Identity:
233-162-8
Details on test material:
- Name of test material (as cited in study report): Chlorine dioxide, ClO2
- Lot/Batch number: None – in situ generation: method and equipment provided by ELF ATOCHEM
- Description: Gas
- Purity: Residual chlorine: maximum 3 ppm
- Stability: Extemporaneous generation was used
- Impurities: residual chlorine, maximum 3 ppm
- Molecular Mass: 67.5 g

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Charles River France
- Age at study initiation: 6-8 weeks
- Weight at study initiation: 175-250 g (males), 150-200 g (females)
- Fasting period before study: no data
- Housing: in individual cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): filtered water ad libitum
- Acclimation period: the minimum acclimatization period lasted for 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22° ± 2°C
- Humidity (%): 30% minimum
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): 12 hours dark/ 12 hours light

IN-LIFE DATES: no data

Administration / exposure

Route of administration:
inhalation: gas
Type of inhalation exposure:
other: oro-nasal
Vehicle:
other: no data
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: oro-nasal exposure chamber is composed of a vertical stainless steel cylinder. It included 4 movables stages. The 2 middle stages contained glass cylinders, nested radially. The upper part of the chamber included tubes for the inlet of the test atmosphere.
- Exposure chamber volume: 2 L
- Method of holding animals in test chamber: cylinder
- System of generating vapor: procuded by a device according to the method described in the ref 95/TEPO/0257/MV-724700 ELF ATOCHEM. According to the wanted concentration of chlorine dioxide, a peristaltic pump introduced a fitted volume of a 100 g/L sodium chlorite solution in a balloon flask containing sulphuric acid (5 N). This balloon had three exhaust and inlet manifolds. At the same time, an airflow was introduced by bubbling in this balloon. This constant air flow (300 L/hour) was manages by a rotameter and was measured by a gas meter. This airflow containing chlorine dioxide was propelled in a second balloon to be washed by bubbling in a sodium chlorite solution (100 g/L). This solution was renewed continuously, in order to maintain acidic pH. This washing allowed to eliminate traces of residual chlorine. At the washing balloon exhaust, gas flow was diluted before to be carried along into the rats exposure cylinder. The final air flow was 1060 L/hour, which corresponds to 530 changes per hour.
- Treatment of exhaust air: at chamber emergence, waste was processed before being rejected into the atmosphere.
- Temperature, humidity, pressure in air chamber:

TEST ATMOSPHERE
- Brief description of analytical method used: iodometry
Analytical verification of test atmosphere concentrations:
yes
Duration of exposure:
h
Concentrations:
Nominal concentration: 0, 45, 70, 106 and 129 mg/m³
Analytical concentration: 0, 46, 71, 107 and 128 mg/m³
No. of animals per sex per dose:
5 rats/sex/group
Control animals:
yes
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: upon arrival and then daily throughout the 14 days of the study
- Necropsy of survivors performed: yes (complete)
- Other examinations performed: Clinical observations, necropsy and histopathology. Mortality was noted daily.
Statistics:
Method of determination of LD50: Litchfield and Wilcoxon

Results and discussion

Preliminary study (if fixed dose study):
Not applicable
Effect levels
Sex:
male/female
Endpoint:
LC50
Effect level:
89 mg/m³ air
Based on:
test mat.
95% CL:
69 - 119
Exp. duration:
4 h
Remarks:
The LC50 was a calculated value.
Mortality:
See table 7.2.2/1 for mortality data.
Clinical signs:
Clinical signs observed in all dose groups include: respiratory distress (abdominal respiration, noisy respiration, laboured respiration and nasal secretion) and general weakness (piloerection, hunched back, decrease of activity and weight loss / thin body condition).
Body weight:
Early mortality in all but the lowest dose and control groups prevented the evaluation of statistically significant weight changes. Whatever the tested concentration, a delay in the body weight gain with weight loss is observed for 3 days at least after the exposure to chlorine dioxide.
For the lowest dose group rats (no mortality) this period of weight loss is followed by a period of weight gain which appears similar to the control group, and indicates the reversibility of lesions.
Gross pathology:
Lungs from dosed animals showed frequent mottling, redness and depressed areas. Shrunken spleens were also noted in some animals which received ClO2.
The main lesion induced by ClO2 is the destruction of alveolar walls, which creates pulmonary emphysema lesions. This emphysema was found on all rats of the study (except control) whatever the tested concentration. The severity of the lesion is proportional to the dose. The lowest grading is observed with rats exposed to the lowest concentration. The differences of mortality between rats (incidence/precocity) restrict this observation.
Rats found dead early had lesions of edema too.
Other findings:
No data
Any other information on results incl. tables:
Table 7.2.2/1: Table for Acute Toxicity
Dose [mg/m3]
Number of dead /
number investigated
Time of death
Observations
Male
Female
0
0/5
0/5
-
45
0/5
0/5
-
70
3/5
0/5
Day 1 (1), day 9 (2)
106
4/5
2/5
Day 1 (4), day 8 (1), day 13 (1)
129
5/5
4/5
Day 1 (5), day 8 (3), day 9 (1)
LD50 value
89 mg/m3 (32 ppm) with 95% confidence limits: 69 mg/m3 (24.6 ppm) - 119 mg/m3 (41.6 ppm)

Applicant's summary and conclusion

Conclusions:
The LC50 (4 hours) is calculated to be 89.6 mg/m3 (32 ppm) (with 95% confidence limits: 69 mg/m3 (24.6 ppm) - 119 mg/m3 (41.6 ppm)). 
Under the test conditions, Chlorine dioxide gas is classified:
- as very toxic according to the Directive 67/548/EC
- in category 1 according to the CLP regulation (1272/2008)
Executive summary:
In an acute inhalation toxicity study (EU Method B.2 (Acute Toxicity (Inhalation)) conducted in compliance with GLP, groups of young adult Wistar rats were exposed by oro-nasal inhalation to Chlorine Dioxide for 4 hours at concentrations of 0, 45, 70, 106 and 129 mg/m3. Then, animals were observed for 2 weeks post exposure for clinical signs, body weight changes and finally gross autopsy was performed at the end of the experiment.
Clinical signs observed in all dose groups included: respiratory distress and general weakness. Early mortality in all but the lowest dose and control groups prevented the evaluation of statistically significant weight changes. Whatever the tested concentration, a delay in the body weight gain with weight loss is observed for 3 days at least after the exposure to chlorine dioxide. For the lowest dose group rats (no mortality), this period of weight loss is followed by a period of weight gain which appeared similar to the control group, and indicated the reversibility of lesions. Lungs from treated animals showed frequent mottling, redness and depressed area. The main lesion induced by ClO2 is the destruction of alveolar walls, which creates pulmonary emphysema lesions. This emphysema was found on all rats of the study (except control) whatever the tested concentration. The severity of the lesion is proportional to the dose. Animals died by respiratory deficiency.
LC50combined = 89 mg/m3air (95% CL 69 -119 mg/m3).
This acute inhalation study is classified as acceptable. It does satisfy with the guidelines requirements for an inhalation study (EU Method B.2) in the rats. Under the test conditions, Chlorine dioxide gas is classified as very toxic according to the Directive 67/548/EC and in category 1 according to the CLP regulation (1272/2008).
Interpretation of results:
very toxic
Criteria used for interpretation of results:
EU

Keine Kommentare:

Kommentar veröffentlichen